EUVIMEDEUVIMED entdecken
Open Access

The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease

Mengyao Tang iD, Anders Berg, Eugene P Rhee, Andrew S Allegretti, Sagar Nigwekar, S Ananth Karumanchi, James P Lash, Sahir Kalim

Diabetes Care · 2023

DOI: 10.2337/dc22-1399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, 2023. Verfasst von Mengyao Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Diabetes Mellitus, Anemia. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Glycated hemoglobin (HbA1c) can predict risk for microvascular complications in patients with diabetes. However, HbA1c’s reliability in chronic kidney disease (CKD) has been questioned, with concerns including competition from another posttranslational protein modification, carbamylation, acting on the same amino groups as glycation, and anemia with reduced erythrocyte lifespans leading to altered glycation accumulation. We investigated whether carbamylation and anemia modify the impact of HbA1c on renal outcomes in patients with diabetes and CKD. RESEARCH DESIGN AND METHODS In 1,516 participants from the Chronic Renal Insufficiency Cohort study with diabetes and CKD, Cox regression models were applied to evaluate the association between HbA1c and CKD progression (composite of end-stage kidney disease or 50% decline in estimated glomerular filtration rate [eGFR]), stratified by carbamylated albumin (C-Alb) quartiles and anemia. RESULTS The mean eGFR was 38.1 mL/min/1.73 m2, mean HbA1c was 7.5% (58 mmol/mol), and median C-Alb was 8.4 mmol/mol. HbA1c was lower in the higher C-Alb quartiles. During a median follow-up of 6.9 years, 763 participants experienced CKD progression. Overall, higher HbA1c was associated with an increased risk of CKD progression (adjusted hazard ratio 1.07 [95% CI 1.02–1.13]). However, using stratified analyses, HbA1c was no longer associated with CKD progression in the highest C-Alb quartile, but did show a monotonic increase in CKD progression risk across each lower C-Alb quartile (P-interaction = 0.022). Anemia also modified the association between HbA1c and CKD progression (P-interaction = 0.025). CONCLUSIONS In patients with coexisting diabetes and CKD, the association between HbA1c and CKD progression is modified by carbamylation and anemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicDiabetes MellitusAnemiaHumansGlycated HemoglobinCohort StudiesProtein CarbamylationReproducibility of ResultsDisease ProgressionGlomerular Filtration Rate

Substanzen

Glycated Hemoglobin

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
  • Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
  • Department of Medicine, University of Illinois at Chicago, Chicago, IL.

ORCID-Profile: Mengyao Tang

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Tang, M., Berg, A., Rhee, E. P., Allegretti, A. S., Nigwekar, S., Karumanchi, S. A., Lash, J. P., & Kalim, S. (2023). The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care. https://doi.org/10.2337/dc22-1399

Vancouver

Tang M, Berg A, Rhee EP, Allegretti AS, Nigwekar S, Karumanchi SA, et al. The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care. 2023. doi:10.2337/dc22-1399

BibTeX
@article{Tang2023,
  author = {Tang, Mengyao and Berg, Anders and Rhee, Eugene P and Allegretti, Andrew S and Nigwekar, Sagar and Karumanchi, S Ananth and Lash, James P and Kalim, Sahir},
  title = {The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease},
  journal = {Diabetes Care},
  year = {2023},
  doi = {10.2337/dc22-1399}
}
Kostenlos starten →